Last reviewed · How we verify
ropivacaine plus mepivacaine
ropivacaine plus mepivacaine is a Small molecule drug developed by Centre Hospitalier Universitaire, Amiens. It is currently FDA-approved.
At a glance
| Generic name | ropivacaine plus mepivacaine |
|---|---|
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach (NA)
- Peripheral Nerve Blocks vs Selective Spinal Anesthesia in Patients With Femur Fracture (NA)
- Plantar Compartment Block Versus Sciatic Block in Hallux Valgus Ambulatory Surgery (NA)
- Dexamethasone or Dexmedetomidine as Adjunct in Fascia Iliaca Block During Positioning for Sub-arachnoid Block & Post-operative Analgesia After Femur Neck Fracture Surgery: A Randomized Control Trial (PHASE4)
- Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction (NA)
- Decision Support for Intraoperative Low Blood Pressure (NA)
- IPACK Nerve Block for Total Knee Arthroplasty (PHASE4)
- Retroclavicular Versus Supraclavicular Brachial Plexus Block for Hand and Forearm Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ropivacaine plus mepivacaine CI brief — competitive landscape report
- ropivacaine plus mepivacaine updates RSS · CI watch RSS
- Centre Hospitalier Universitaire, Amiens portfolio CI
Frequently asked questions about ropivacaine plus mepivacaine
What is ropivacaine plus mepivacaine?
ropivacaine plus mepivacaine is a Small molecule drug developed by Centre Hospitalier Universitaire, Amiens.
Who makes ropivacaine plus mepivacaine?
ropivacaine plus mepivacaine is developed and marketed by Centre Hospitalier Universitaire, Amiens (see full Centre Hospitalier Universitaire, Amiens pipeline at /company/centre-hospitalier-universitaire-amiens).
What development phase is ropivacaine plus mepivacaine in?
ropivacaine plus mepivacaine is FDA-approved (marketed).
Related
- Manufacturer: Centre Hospitalier Universitaire, Amiens — full pipeline